東雅惠-en – NYCU

Associate Professor YAA-HUI DONG

Mail : ydong3@nycu.edu.tw

Tel : 02-28267000#67986

Education

2008 ~2012 Ph.D., Institute of Epidemiology and Preventive Medicine, National Taiwan University
1999 ~2001 M.S., Master of Hospital Pharmacy, National Taiwan University Institute of Pharmacy
1994 ~1998 B.S., Department of Pharmacy, National Taiwan University

Experience

Postdoctoral researcher, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, US
Postdoctoral researcher, Health Data Research Center

Professional Specialty

Pharmacoepidemiology, Health data analysis

Selected Publication

(*corresponding author, #equal contribution)

Dong YH, Chang CH*, Lin JW*, Yang WS, Wu LC, Toh S (2022, May). Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. 2022 May 1. doi: 10.1111/dom.14741. Online ahead of print.
Dong YH*, Chang CH*, Wang JL, Wu LC, Lin JW, Toh S (2020, Dec). Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med. 2020;180:1587-1595.
Dong YH, Jin Y, Tsacogianis TN, He M, Hsieh PH, Gagne JJ* (2018, Mar). Use of olmesartan and enteropathy outcomes: a multi-database study. Aliment Pharmacol Ther. 2018;47:792-800.
Dong YH#, Chang CH#, Wu FL, Shen LJ, Calverley PMA, Löfdahl CG, Lai MS*, Mahler DA (2014, Jun). Use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease and the risk of tuberculosis and influenza: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145:1286-1297.
Dong YH, Lin HH, Shau WY, Wu YC, Chang CH*, Lai MS* (2013, Jan). Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax. 2013;68:48-56.